联合医务2022年报

Annual Report 2022 年報 CONTENTS 目錄2Corporate Information公司資料4Financial Highlights財務摘要8Chairman Statement主席報告12Management Discussion and Analysis管理層討論及分析36Biographical Details of Directors董事履歷46Corporate Governance Report企業管治報告67Environmental, Social and Governance Report環境、社會及管治報告103Report of Directors董事會報告141Independent Auditor’s Report獨立核數師報告149Consolidated Statement of Profit or Loss綜合損益表150Consolidated Statement of Comprehensive Income綜合全面收入表151Consolidated Statement of Financial Position綜合財務狀況表153Consolidated Statement of Changes in Equity綜合權益變動表155Consolidated Statement of Cash Flows綜合現金流量表158Notes to the Consolidated Financial Statements綜合財務報表附註304Financial Summary財務概要305Glossary詞彙This annual report is printed on environmentally friendly paper本年報以環保紙印製 UMP HEALTHCARE HOLDINGS LIMITED • 2022 ANNUAL REPORT2CORPORATE INFORMATION公司資料BOARD OF DIRECTORSExecutive DirectorsDr. Sun Yiu Kwong (Chairman and Chief Executive Officer)Ms. Kwok Cheuk Kwan, Jacquen (Managing Director)Mr. Tsang On Yip, Patrick Dr. Sun Man Kin, Michael Mr. Lee Kar Chung, FelixDr. Lee Pak Cheung, PatrickIndependent Non-executive DirectorsMr. Lee Luen Wai, John BBS JPDr. Li Kwok Tung, Donald SBS JPMr. Yeung Wing Sun, MikeMr. Chau, Chit Jeremy (appointed on 26 November 2021)AUDIT COMMITTEEMr. Lee Luen Wai, John BBS JP (Chairman)Dr. Li Kwok Tung, Donald SBS JPMr. Yeung Wing Sun, MikeREMUNERATION COMMITTEEDr. Li Kwok Tung, Donald SBS JP (Chairman)Mr. Yeung Wing Sun, Mike Mr. Tsang On Yip, PatrickNOMINATION COMMITTEEDr. Sun Yiu Kwong (Chairman) Mr. Lee Luen Wai, John BBS JP Dr. Li Kwok Tung, Donald SBS JPAUTHORISED REPRESENTATIVESMr. Lee Kar Chung, Felix Ms. Ma Hoi Wan (resigned on 4 January 2022)Mr. Au In Kee, Adam (appointed on 4 January 2022)COMPANY SECRETARYMs. Ma Hoi Wan (resigned on 4 January 2022)Mr. Au In Kee, Adam (appointed on 4 January 2022)HEADQUARTERS AND PRINCIPAL PLACE OF BUSINESS27th Floor Wing On House71 Des Voeux Road Central Hong Kong董事會執行董事孫耀江醫生（主席兼行政總裁）郭卓君女士（董事總經理）曾安業先生孫文堅醫生李家聰先生李柏祥醫生獨立非執行董事李聯偉先生（銅紫荊星章，太平紳士）李國棟醫生（銀紫荊星章，太平紳士）楊榮燊先生周哲先生（於2021年11月26日獲委任）審核委員會李聯偉先生（銅紫荊星章，太平紳士）（主席）李國棟醫生（銀紫荊星章，太平紳士）楊榮燊先生薪酬委員會李國棟醫生（銀紫荊星章，太平紳士）（主席）楊榮燊先生曾安業先生提名委員會孫耀江醫生（主席）李聯偉先生（銅紫荊星章，太平紳士）李國棟醫生（銀紫荊星章，太平紳士）授權代表李家聰先生馬凱雲女士（於2022年1月4日辭任）歐衍基先生（於2022年1月4日獲委任）公司秘書馬凱雲女士（於2022年1月4日辭任）歐衍基先生（於2022年1月4日獲委任）總部及主要營業地點香港德輔道中71號永安集團大廈27樓 2022年報 • 聯合醫務集團有限公司3CORPORATE INFORMATION公司資料財政年度年結日6月30日股份代號722每手買賣單位2,000股股份已發行股份792,666,555（於2022年6月30日）註冊辦事處Cricket Square Hutchins Drive PO Box 2681Grand Cayman KY1-1111 Cayman Islands開曼群島主要股份過戶登記處Conyers Trust Company (Cayman) Limited Cricket SquareHutchins Drive PO Box 2681Grand Cayman KY1-1111 Cayman Islands香港股份過戶登記分處卓佳證券登記有限公司香港夏愨道16號遠東金融中心17樓（自2022年8月15日起生效）核數師畢馬威會計師事務所《財務匯報局條例》下的 註冊公眾利益實體核數師法律顧問安理國際律師事務所主要往來銀行恒生銀行有限公司公司網站www.ump.com.hkFINANCIAL YEAR END30 JuneSTOCK CODE722BOARD LOT 2,000 shares ISSUED SHARES 792,666,555 (as at 30 June 2022)REGISTERED OFFICECricket Square Hutchins Drive PO Box 2681Grand Cayman KY1-1111 Cayman IslandsPRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDSConyers Trust Company (Cayman) Limited Cricket SquareHutchins Drive PO Box 2681Grand Cayman KY1-1111 Cayman IslandsHONG KONG BRANCH SHARE REGISTRARTricor Investor Services Limited 17/F, Far East Finance Centre16 Harcourt Road, Hong Kong (with effect from 15 August 2022)AUDITORKPMGPublic Interested Entity Auditor registered in accordance with the Financial Reporting Council OrdinanceLEGAL ADVISERAllen & OveryPRINCIPAL BANKERHang Seng Bank LimitedCOMPANY WEBSITEwww.ump.com.hk UMP HEALTHCARE HOLDINGS LIMITED • 2022 ANNUAL REPORT4FINANCIAL HIGHLIGHTS財務摘要For the year ended 30 June截至6月30日止年度20222021Increase/(decrease)2022年2021年增加╱（減少） (A)Operating results (HK$’000)(A)經營業績（千港元）Continuing operations:持續經營業務：Revenue收入665,859616,36149,498 8%EBITDA(note a)EBITDA（附註a）167,130161,423 5,7074%Profit/(loss) attributable to Owners of the Company本公司擁有人應佔 利潤╱（虧損）– From continuing operations－來自持續經營業務70,50266,0664,4367%– From discontinued operation－來自已終止經營 業務1,666(31,232)32,898 105% Total總計72,16834,83437,334107% (B)Per share data (HK cents)(B)每股數據（港仙）Earnings per share – basic每股盈利－基本9.344.584.76104%Earnings per share – diluted每股盈利－攤薄9.334.584.75104%Dividends per share每股股息– Proposed final－擬派末期3.002.800.207%– Paid interim－已付中期1.501.000.5050% Total總計4.503.800.7018% (C)Financial Position (HK$’000)(C)財務狀況（千港元）Cash and pledged deposits現金及抵押存款238,120295,867 (57,747)(20%)Shareholders’ funds股東資金698,653639,49859,1559% (D)Key ratios (%)(D)主要比率(%)EBITDA/Revenue – continuing operationsEBITDA╱收入－持續經營業務25%26%(1%)Net profit margin純利率11%5%6%Return on shareholders’ funds股東資金回報率10%5%5% Note a: EBITDA represented profit for the year from continuing operations plus the following to the extent deducted in calculating such profit for the year: finance costs, income tax expenses, depreciation and amortisation.附註a： EBITDA代表本年度來自持續經營業務的利潤加上在計算年度利潤時扣除的以下各項：融資成本、所得稅費用、折舊及攤銷。 2022年報 • 聯合醫務集團有限公司5FINANCIAL HIGHLIGHTS財務摘要FINANCIAL PERFORMAN